Oruka Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	46.94	61.58	37.43	42.45	53.36
Short-Term Investments	290.11	314.07	-	-	-
Cash & Short-Term Investments	337.04	375.65	37.43	42.45	53.36
Cash Growth	-10.28%	903.58%	-11.81%	-20.45%	8.74%
Other Current Assets	6.81	1.22	0.16	0.25	1.06
Total Current Assets	343.86	376.87	37.59	42.7	54.42
Net Property, Plant & Equipment	2.12	1.04	0.26	0.37	0.49
Long-Term Investments	142.54	18.07	-	-	-
Other Long-Term Assets	0.1	0.04	0.01	0.02	0.02
Total Assets	488.62	396.02	37.86	43.09	54.92
Accounts Payable	4.16	3.46	0.36	0.33	1.12
Accrued Expenses	10.59	3.35	0.28	0.17	2.38
Current Portion of Leases	0.62	0.21	-	-	-
Other Current Liabilities	0.01	6.02	-	0.63	-
Total Current Liabilities	15.37	13.04	0.64	1.13	3.5
Long-Term Leases	1.31	0.76	0.2	0.28	0.38
Total Long-Term Liabilities	1.31	0.76	0.2	0.28	0.38
Total Liabilities	16.69	13.8	0.84	1.41	3.88
Preferred Stock	2.93	2.93	-	-	-
Common Stock	0.05	0.04	0.01	0.01	0.01
Additional Paid-in Capital	657.56	463.02	225.75	225.06	224.51
Accumulated Other Comprehensive Income	0.55	-0.04	-	-	-
Retained Earnings	-189.16	-83.72	-188.74	-183.4	-173.48
Shareholders' Equity	471.93	382.22	37.02	41.67	51.04
Total Liabilities & Equity	488.62	396.02	37.86	43.09	54.92
Total Debt	1.93	0.97	0.2	0.28	0.38
Net Cash (Debt)	335.11	374.68	37.23	42.17	52.98
Net Cash Growth	-10.56%	906.47%	-11.71%	-20.41%	8.87%
Net Cash Per Share	7.35	22.32	30.99	35.11	45.72
Book Value	471.93	382.22	37.02	41.67	51.04
Book Value Per Share	10.35	22.77	30.82	34.70	44.05
Tangible Book Value	471.93	382.22	37.02	41.67	51.04
Tangible Book Value Per Share	10.35	22.77	30.82	34.70	44.05

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q